Evotec (EVO)
(Delayed Data from NSDQ)
$4.70 USD
-0.02 (-0.42%)
Updated Jun 26, 2024 04:00 PM ET
After-Market: $4.70 0.00 (0.00%) 5:54 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Brokerage Reports
Evotec AG [EVO]
Reports for Purchase
Showing records 1 - 8 ( 8 total )
Company: Evotec AG
Industry: Medical - Drugs
Soft 1Q Performance Not a Big Surprise, Expect Recovery In 2H24; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
A Needed "Reset" Though Uncertainty Persists; Lower PT to $11; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
Optimized Entry and Exit Levels for EVO 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Evotec AG
Industry: Medical - Drugs
Evotec Emerges Stronger Following Cyberattack; PT Up to $14; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
Evotec Reaps Rewards from Collaboration with Bristol Myers Squibb
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
Evotec''s Advances in Drug Discovery, Development and Manufacturing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
Company: Evotec AG
Industry: Medical - Drugs
Stepping on the Accelerator of Drug Development; Initiate at Buy With $12 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
|